European action on secondary and primary prevention of coronary heart disease in order to reduce events (part III)

European action on secondary and primary prevention of coronary heart disease in order to reduce events (part III) - EUROASPIRE III

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30196

Enrollment

800

Registered

2006-12-07

Start date

2006-12-14

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis Coronary heart disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
This multicenter European study will identify risk factors in coronary patients, their blood relatives and high risk individuals, describe their management through lifestyle and use of drug therapies and provide an objective assessment of clinical implementation of current scientific knowledge. All centres and countries, which participated in the first two surveys, will be invited to participate in EUROASPIRE III and the number of countries and centres will be increased to cover an even larger geographic area. In addition, the survey will be extended beyond coronary patients and first-degree blood relatives to include high-risk individuals in primary care with medically treated hypertension, dyslipidaemia and diabetes. In this way this third survey will cover the complete spectrum of preventive cardiology as defined in the guidelines: coronary patients, relatives and high-risk individuals. The EUROASPIRE III survey will give a unique European picture of preventive action by cardiologists, other specialists and primary care physicians looking after patients with coronary disease and their families, and individuals at high risk of CVD.	—

Measure

Time frame

This multicenter European study will identify risk factors in coronary patients, their blood relatives and high risk individuals, describe their management through lifestyle and use of drug therapies and provide an objective assessment of clinical implementation of current scientific knowledge. All centres and countries, which participated in the first two surveys, will be invited to participate in EUROASPIRE III and the number of countries and centres will be increased to cover an even larger geographic area. In addition, the survey will be extended beyond coronary patients and first-degree blood relatives to include high-risk individuals in primary care with medically treated hypertension, dyslipidaemia and diabetes. In this way this third survey will cover the complete spectrum of preventive cardiology as defined in the guidelines: coronary patients, relatives and high-risk individuals. The EUROASPIRE III survey will give a unique European picture of preventive action by cardiologists, other specialists and primary care physicians looking after patients with coronary disease and their families, and individuals at high risk of CVD.

—

Secondary

Measure	Time frame
Comparison of current data with previous (1995, 1999) findings.	—

Countries

Netherlands

Outcome results